
Lisa Woods on Walmart’s Center of Excellence strategy
Suzanne Delbanco calls up Lisa Woods, Senior Director of Health Care Benefits at Walmart Stores, Inc., to discuss Walmart’s efforts to control costs and deliver high-value health care using a
Suzanne Delbanco calls up Lisa Woods, Senior Director of Health Care Benefits at Walmart Stores, Inc., to discuss Walmart’s efforts to control costs and deliver high-value health care using a
The baby boomers are aging the United States’ population at an unprecedented rate. Some are calling it the Silver Tsunami. Approximately 10,000 baby boomers turn 65 every day and, by
Suzanne Delbanco checks in with Mike Stull, Chief Marketing Officer at Employers Health Coalition, to talk all things pharmacy. Listen in as Suzanne and Mike discuss what employers and health
Suzanne Delbanco, CPR’s Executive Director, checks in with Debbie Welle-Powell, Chief Population Health Officer at Essentia Health, an integrated health system in the Midwest. Debbie and Suzanne discuss the definition
A new year always offers a chance for fresh perspective. Keeping the pulse on CPR’s leading edge employer-purchaser members, I truly sense that we are entering an era in which
As the availability and utility of big data continues to grow by the day, Catalyst for Payment Reform has set out to better understand how employers are using data to
Suzanne Delbanco dials up Emily Transue, MD, Associate Medical Director for Clinical Quality and Care Transformation at the Washington State Health Care Authority (HCA). They discuss HCA’s shared decision making
Climate change is the greatest health concern of the 21stcentury. It threatens our national and global political, economic and social stability. It threatens the very existence of human life. Just
Suzanne Delbanco dials up Ann Greiner, President and CEO of the Patient-Centered Primary Care Collaborative (PCPCC), to discuss the patient centered medical home (PCMH) model. Ann shares where the PCMH
Over the last several years, of all efforts to reform care delivery, health plans most prolifically adopted and implemented accountable care organizations (ACOs). As of August 2018, there were 1,011
Suzanne Delbanco checks in with David Schleifer, Ph.D.,Vice President and Director of Research at Public Agenda, a nonpartisan, nonprofit research and public engagement organization that works to strengthen democracy and
Suzanne calls Frederick Isasi, Executive Director of Families USA, to understand the aspects of today’s health care insurance landscape that are putting the greatest strain on families. They discuss prescription
At the risk of sounding like a broken record, once again Kaiser Family Foundation’s 2018 annual survey of employers demonstrated how health care costs in the United States continue to
Suzanne Delbanco calls Mai Pham, MD, Vice President of Provider Alignment Solutions at Anthem Inc., and former Chief Innovation Officer at CMMI, to discuss the Medicare Physician Fee Schedule. They
More than 1.6 million Americans are diagnosed with cancer each year. These diagnoses led to over 600,000 deaths in 2016 alone. Put another way, 38.4% of American men and women
Over the past several years, many large self-funded employers have been implementing value-oriented strategies in an attempt to bend the rising cost curve and improve care for their populations. Large
Suzanne dials up her provider payment “guru”- Bob Berenson of the Urban Institute. Bob draws on his 20 years experience as an internal medicine doctor to answer Suzanne’s questions about
Thinking about offering CDHPs? Read my story first. Looking back on open enrollment last year, I can see that my choice to enroll in a high-deductible health plan – also
Can states combat rising prescription drug costs? The rising costs of prescription drugs is a high priority for patients, providers, payers, and purchasers at the state and federal levels. Kaiser
Andréa Caballero speaks with David Muhlestein, Chief Research Officer at Leavitt Partners, about his latest research titled “Growth of Population-Based Payments is Not Associated With a Decrease in Market-Level Cost